Cargando…

Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience

BACKGROUND: In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer. To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gez...

Descripción completa

Detalles Bibliográficos
Autores principales: Elhassan, Moawia Mohammed Ali, Gismalla, Mohamed Dafalla Awadalla, Mohamed, Sahar Abdelrahman Hamid, Faggad, Areeg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463320/
https://www.ncbi.nlm.nih.gov/pubmed/37626413
http://dx.doi.org/10.1186/s13044-023-00173-5
_version_ 1785098203222245376
author Elhassan, Moawia Mohammed Ali
Gismalla, Mohamed Dafalla Awadalla
Mohamed, Sahar Abdelrahman Hamid
Faggad, Areeg
author_facet Elhassan, Moawia Mohammed Ali
Gismalla, Mohamed Dafalla Awadalla
Mohamed, Sahar Abdelrahman Hamid
Faggad, Areeg
author_sort Elhassan, Moawia Mohammed Ali
collection PubMed
description BACKGROUND: In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer. To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gezira (NCI-UG), Sudan. METHODS: We performed a retrospective health facility–based study of patients with thyroid cancer who were treated at NCI–UG from January 2009 to December 2017. RESULTS: A total of 139 patients with thyroid cancer were identified during the study period. Tumors were more common among women (69%). Goiter was the main presenting symptom (85%). The most common type of thyroid cancer was follicular carcinoma (41%), followed by papillary carcinoma (24%), then anaplastic carcinoma (20%). The mean age of the women was 56.3 years (SD ± 14.7), compared to 52.5 years (SD ± 16.6) for the men. The frequencies of stage I, II, III, and IV were 17%, 22%, 16%, and 45%, respectively. Different types of thyroidectomies were performed in 79% of the cases, lobectomy in 4%, and no surgery in 17%. Only 28% of the cases received radioactive iodine. Palliative chemotherapy and radiotherapy were prescribed to 17% and 37% of the cases, respectively. CONCLUSION: Thyroid cancer is more prevalent among women and most patients present at later stages. The dominance of follicular type suggests that the majority of this population is iodine-deficient. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13044-023-00173-5.
format Online
Article
Text
id pubmed-10463320
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-104633202023-08-30 Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience Elhassan, Moawia Mohammed Ali Gismalla, Mohamed Dafalla Awadalla Mohamed, Sahar Abdelrahman Hamid Faggad, Areeg Thyroid Res Research BACKGROUND: In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer. To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gezira (NCI-UG), Sudan. METHODS: We performed a retrospective health facility–based study of patients with thyroid cancer who were treated at NCI–UG from January 2009 to December 2017. RESULTS: A total of 139 patients with thyroid cancer were identified during the study period. Tumors were more common among women (69%). Goiter was the main presenting symptom (85%). The most common type of thyroid cancer was follicular carcinoma (41%), followed by papillary carcinoma (24%), then anaplastic carcinoma (20%). The mean age of the women was 56.3 years (SD ± 14.7), compared to 52.5 years (SD ± 16.6) for the men. The frequencies of stage I, II, III, and IV were 17%, 22%, 16%, and 45%, respectively. Different types of thyroidectomies were performed in 79% of the cases, lobectomy in 4%, and no surgery in 17%. Only 28% of the cases received radioactive iodine. Palliative chemotherapy and radiotherapy were prescribed to 17% and 37% of the cases, respectively. CONCLUSION: Thyroid cancer is more prevalent among women and most patients present at later stages. The dominance of follicular type suggests that the majority of this population is iodine-deficient. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13044-023-00173-5. BioMed Central 2023-08-25 /pmc/articles/PMC10463320/ /pubmed/37626413 http://dx.doi.org/10.1186/s13044-023-00173-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Elhassan, Moawia Mohammed Ali
Gismalla, Mohamed Dafalla Awadalla
Mohamed, Sahar Abdelrahman Hamid
Faggad, Areeg
Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
title Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
title_full Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
title_fullStr Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
title_full_unstemmed Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
title_short Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience
title_sort clinicopathological profile and management of thyroid carcinoma: a sub-saharan country experience
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463320/
https://www.ncbi.nlm.nih.gov/pubmed/37626413
http://dx.doi.org/10.1186/s13044-023-00173-5
work_keys_str_mv AT elhassanmoawiamohammedali clinicopathologicalprofileandmanagementofthyroidcarcinomaasubsaharancountryexperience
AT gismallamohameddafallaawadalla clinicopathologicalprofileandmanagementofthyroidcarcinomaasubsaharancountryexperience
AT mohamedsaharabdelrahmanhamid clinicopathologicalprofileandmanagementofthyroidcarcinomaasubsaharancountryexperience
AT faggadareeg clinicopathologicalprofileandmanagementofthyroidcarcinomaasubsaharancountryexperience